MCL1 and glioblastoma: In addition, in silico analysis based on the TCGA data set revealed a 5-fold overexpression of Mcl-1 mRNA in glioblastoma when compared to normal brain (Supplementary Figure 1) suggesting that Mcl-1 represents a valid target in this disease.